CAHIC(SH:600195)2014-10-29 16:00Financial Performance - Operating revenue for the first nine months rose by 6.08% to CNY 2,570,447,416.27 year-on-year[7] - Net profit attributable to shareholders decreased by 6.33% to CNY 238,867,138.93 for the first nine months[7] - Basic and diluted earnings per share fell by 14.99% to CNY 0.5558[8] - Total operating revenue for Q3 2014 was ¥989,906,614.69, an increase of 5.0% compared to ¥936,568,113.18 in Q3 2013[36] - Net profit for Q3 2014 reached ¥90,476,424.10, representing a 11.4% increase from ¥81,439,391.16 in Q3 2013[38] - The company reported a total profit of ¥110,497,245.21 for Q3 2014, which is a 10.2% increase from ¥100,295,832.27 in Q3 2013[38] - The total comprehensive income for Q3 2014 was ¥90,662,889.30, compared to ¥81,311,048.70 in Q3 2013, indicating a growth of 10.5%[38] - The net profit for Q3 2014 was 92,828,715.88 CNY, compared to 74,206,451.19 CNY in the same period last year, reflecting a year-over-year increase of approximately 25.2%[42] Assets and Liabilities - Total assets increased by 12.01% to CNY 4,160,074,674.79 compared to the end of the previous year[7] - Cash and cash equivalents decreased by 59.29% to ¥388,462,579.46 from ¥954,124,902.23 due to normal operating expenses[14] - Accounts receivable increased by 110.78% to ¥852,457,546.74, primarily due to government procurement payments not yet settled[14] - Total liabilities rose to CNY 1,044,543,004.13 from CNY 877,214,682.21, marking an increase of around 19.0%[29] - The company reported a total current liabilities of CNY 974,043,613.91, up from CNY 781,954,946.71, an increase of approximately 24.6%[29] - Total liabilities as of the end of Q3 2014 amounted to ¥685,142,998.26, an increase of 34.0% from ¥511,210,225.43 at the end of Q3 2013[33] Cash Flow - Net cash flow from operating activities improved significantly, with a reduction in outflow from CNY -413,049,816.69 to CNY -36,546,873.69[7] - Cash inflow from operating activities for the first nine months of 2014 was 2,370,886,197.25 CNY, up from 2,079,409,978.88 CNY year-over-year[45] - The company reported a total cash outflow from financing activities of 453,263,483.92 CNY in Q3 2014, compared to 111,122,391.03 CNY in the same period last year[46] - Investment activities generated a net cash outflow of 267,851,992.79 CNY for the first nine months of 2014, compared to -128,235,773.55 CNY in the previous year[45] Investments and Growth Plans - The company plans to continue expanding its market presence and invest in new product development[6] - The company plans to expand production capacity and improve product quality through increased capital expenditures[14] - Investment income grew by 52.95% to ¥41,133,483.51, reflecting improved performance of Xiamen Jindawei Group Co., Ltd.[14] - Cash paid for investment surged by 793.57% to ¥60,978,702.68, primarily for the acquisition of Shandong Victory Bioengineering Co., Ltd.[15] - The company is focusing on expanding its market presence and developing new products and technologies to enhance its competitive edge[23] Shareholder Information - The total number of shareholders reached 27,497 by the end of the reporting period[10] - The largest shareholder, China Animal Husbandry Group, holds 53.05% of the shares[10] Accounting and Standards - The company has implemented revised accounting standards for long-term equity investments, impacting only the financial statement items of available-for-sale financial assets and long-term equity investments[23] - The weighted average return on net assets decreased by 3.50 percentage points to 8.76%[8]